|
| Friday, November 6, 2015 |
|
|
Scratching the Surface of Skin Disease |
| An international team of scientists, led by researchers from A*STAR's Genome Institute of Singapore (GIS), Institute of Medical Biology (IMB), and Bioinformatics Institute (BII), and P&G, have completed the first comprehensive genomic and biologic study of all species of Malassezia, one of the top skin disease-causing microbes. more info >> |
|
| Wednesday, November 4, 2015 |
|
|
Two A*STAR Scientists Clinch Prestigious 2015 EMBO Young Investigator Awards |
| Two A*STAR scientists have joined 21 other scientists as EMBO Young Investigators, becoming part of an international network that represents some of the best young researchers in Europe and beyond. more info >> |
|
| Thursday, October 29, 2015 |
|
|
A*STAR Findings on Breast Cancer Hold Potential for New Treatments |
| Scientists at the Bioinformatics Institute (BII) and Genome Institute of Singapore (GIS), research institutes under the Agency for Science, Technology and Research (A*STAR), have made discoveries that could lead to new ways of diagnosing and treating breast cancer. more info >> |
|
| Monday, September 21, 2015 |
|
|
A*STAR Scientists Reveal How Stem Cells Defend Against Viruses |
| Scientists from the Institute of Molecular and Cell Biology, a research institute under the Agency for Science, Technology and Research, Singapore, have uncovered the mechanisms which embryonic stem cells employ to inhibit virus expression. The ground-breaking discovery could potentially advance stem cell therapeutics and diagnostics. more info >> |
|
| Thursday, July 16, 2015 |
|
|
First Made-in-Singapore Cancer Drug Enters Clinical Testing |
| A made-in-Singapore cancer drug has advanced into clinical trials, charting a milestone in Singapore's biomedical sciences initiative that will go towards improving the lives of cancer patients in Singapore, and worldwide. more info >> |
|
| Tuesday, July 14, 2015 |
|
|
Agilent Technologies and A*STAR's Bioprocessing Technology Institute Collaborate on New Bioanalytical Methodologies |
| Agilent Technologies Inc. (NYSE: A) and the Bioprocessing Technology Institute (BTI), a research institute of Singapore's Agency for Science, Technology and Research (A*STAR) today announced that they will collaborate on new analytical approaches to analyzing specific protein-linked sugar compounds. more info >> |
|
| Friday, May 29, 2015 |
|
|
Finding Loopholes in the Genome: First-of-its-Kind Predictive Tool to Identify Sequences Susceptible to Causing Mutations, Genome Instability and Diseases |
| Scientists from A*STAR's Bioinformatics Institute (BII) have developed an analytical model and computational tool to rapidly and accurately predict the occurrence and locations of R-loop Forming Sequences (RLFSs) in any genome or artificial nucleic acid sequences. more info >> |
|
| Wednesday, February 4, 2015 |
|
|
Infant Gut Microbiota Linked With Gestation Duration, Delivery Method and Healthy Weight Gain |
| Researchers in Singapore and UK as part of the EpiGen consortium worked together with scientists at the Nestle Research Center, Switzerland, on a new study on the bacterial makeup of the gut (gut microbiota) of infants in Singapore. more info >> |
|
| Friday, December 19, 2014 |
|
|
A*STAR Scientists Discover Gene Critical for Proper Brain Development |
| Scientists at A*STAR's Institute of Medical Biology (IMB) and Institute of Molecular and Cellular Biology (IMCB) have identified a genetic pathway that accounts for the extraordinary size of the human brain. more info >> |
|
| Wednesday, December 17, 2014 |
|
|
Anti-Diabetic Drug Springs New Hope for Tuberculosis Patients |
| A more effective treatment for tuberculosis (TB) could soon be available as scientists have discovered that Metformin (MET), a drug for treating diabetes, can also be used to boost the efficacy of TB medication without inducing drug resistance. more info >> |
|
|
|
|
